This is 12-month outlook for IOVA from several different angles (meaning sized bars, heavy emphasis on 1-day and 2-day). Temporary weakness in volume structure has been considered and expected to resolve by January 2021. Future looks bright.
Hey traders, IOVANCE BIOTHERAPEUTICS is in a bullish continuation with a large stable buying volume at the end of the session. And she broke the VWAP by force, on the TIMEFRAME 5 Min. It takes off from the same VWAP in the TIMEFRAME 1 Min, we can notice a doji bull candle with a refusal from the buyers. In this situation as at the top of the consolidation zone, it...
IOVA bumping into 2.5 month long resistance.
Hammer right at major structure and 618. Beautiful long here for a reversal and continued upside. Notice, the intraday neckline is the 618 of the daily. And there's more! There is also a trend line that seems to be important.. A LOT of confluence.
Biotech stocks have shown relentless strength lately, including $IOVA. I wouldn't be surprised to see that IOVA rejects this move downward soon and soars back up (i.e., reverts to trend). That moving average keeps cranking higher.
Hammer on daily. Breakout at 8 EMA could push it towards mid to high 30s.
VIRGIN GALACTIC MRNA APT IOVA STOCK CHARTS!!!
trying rest 21.41 again ..we shall see , but shorts having good day imo or week already
12.7.19 a story about a hard working guy that I met.
*****CONTINUATION LOOKS ON THE CARDS TODAY, STRONG GAINS THE AFTER HOURS ONCE AGAIN ON GOOD VOLUME . CURRENTLY ON RESISTANCE AT $18 A BREAK COULD BE VERY REWARDING. ***********NEWS FLOW********* The FDA designates Iovance Biotherapeutics' (NASDAQ:IOVA) LN-145 a Breakthrough Therapy for the treatment of recurrent, metastatic, or persistent cervical cancer that...
******CONTINUATION LOOKS ON THE CARDS TOMORROW, STRONG GAINS THE AFTER HOURS ONCE AGAIN ON GOOV VOLUME. CURRENTLY ON RESISTANCE AT $18 A BREAK COULD BE VERY REWARDING. ***********NEWS FLOW********* The FDA designates Iovance Biotherapeutics' (NASDAQ:IOVA) LN-145 a Breakthrough Therapy for the treatment of recurrent, metastatic, or persistent cervical cancer that...